Tipifarnib and Osimertinib in EGFR-mutated Non-Small Cell Lung Cancer
Clinical trial NCT05693090 · WITHDRAWN
Trial details
- NCT number
- NCT05693090
- Sponsor
- Kura Oncology, Inc.
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-01
- Primary completion
- 2027-07-27
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.